SciELO - Scientific Electronic Library Online

 
vol.13 número5Disfunción sexual asociada al uso de gabapentina en el tratamiento del dolor centralFisiopatología y tratamiento del dolor neuropático: avances más recientes índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista de la Sociedad Española del Dolor

versión impresa ISSN 1134-8046

Resumen

ARBAIZA, D.. Botulinum toxin type A for the treatment of tension-type headache. Rev. Soc. Esp. Dolor [online]. 2006, vol.13, n.5, pp.303-311. ISSN 1134-8046.

Objectives: To determine the time of onset of the analgesia, the < ficacy and the security of the application of the botulinu toxin A (BTA) in patient with tension-type headache (TH). Material and methods: Inclusion criteria: patients between 18 and 70 yeai diagnosis of TH according to the International Headache S ciety, two or more episodes of TH per month during at lea 3 months, non controlled TH with the standard treatmei normal neurological examination and signed inform consei Variables analyzed: Intensity of headache (IH), frequency presentation of headache (FH), duration of headache (DH sensibility to digit pressure (SDP) of the cranial musculatur number of painful points (NPD) of the cranial musculatur time of onset of the analgesia (TBA), time until the ma: mum effect of analgesia (TMA) and decrease of use of an.gesics (DUA). Evaluations in the days 0, 15 and 30. Fifty units of BT were applied to cranial musculature. The patients could continue with their previous analgesic therapy according to the evolution of the headache. Results: Twenty female patients were included with a median age of 47 years. IH 2.15 in the first evaluation diminished at 1.05 and 0.9 in the second and third evaluations (p=0.009 and 0.008). FH of 10.25 days diminished to 3.6 and 2.75 days (p=0.008 and 0.012). DH of 2.3 daily hours it diminished at 1.3 and 1.1 (p=0.009 in both). SDP 1.55 diminished at 0.5 and 0.55 (p=0.008 in both). NPD 2.65 diminished at 0.8 and 0.6 (p=0.010 and 0.006). TBA was 8 days and TMA was 25 days. DUA 5 diminished at 1.9 and 1.5. Around of 35% of the patients presented a probable adverse event of mild or moderate severity. Conclusion: TB-TO it is a simple, effective treatment and provides control of the TH. The technique is easy to reproduce. More studies are needed to value the number of applications and the total area of application, as probable factors in the analgesic response.

Palabras clave : Tension-type headache; botulinum toxin A; cranial musculature.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons